Enhancing Elegance: Forecasted CAGR of 12.6% for Global Breast Augmentation Market
The global breast augmentation market is on a trajectory to surpass $1.9 billion by 2030, exhibiting a robust CAGR of 12.6% throughout the forecast period. This growth is primarily fueled by the escalating number of breast augmentation surgeries and the burgeoning awareness surrounding cosmetic surgery.
The demand for cosmetic procedures and aesthetic enhancements is witnessing significant traction globally, with an increasing emphasis on physical appearance. Among these procedures, breast augmentation, also known as breast enlargement or mammoplasty, stands out as the most prevalent aesthetic surgery. It involves a surgical intervention to enhance breast size, typically through the use of implants or fat transfer techniques. Data from the International Society of Aesthetic Plastic Surgery reveals a notable 6.2% increase in breast augmentation procedures during the period from 2025 to 2030.
In terms of geographical segments, the Asia-Pacific (APAC) region emerges as one of the fastest-growing markets, primarily attributed to the rapid adoption of cosmetic surgeries, especially in countries like China and India. Furthermore, Latin America, particularly Brazil, is anticipated to present a lucrative segment due to the high volume of surgeries performed in the region.
Globally, the statistics show a rising trend in breast augmentation procedures. In 2018 alone, 1,862,506 such procedures were performed, marking a significant increase from 1,677,319 procedures in 2017, according to the International Society of Cosmetic Plastic Surgery. The United States accounted for 313,735 breast augmentation procedures in 2018, compared to 300,378 procedures in 2022, as reported by the American Society for Cosmetic Plastic Surgery (ASAPS). This upward trend indicates a growing market for breast augmentation products.
Additionally, the prevalence of Breast Augmentation Market is a major driving factor for the revenue growth of the global breast implant market. The American Cancer Society reported 252,710 new cases of invasive breast cancer in women in 2017, along with 63,410 cases of in situ breast carcinoma. With breast cancer claiming the lives of approximately 40,610 women and 460 men in the same year, the numbers are expected to escalate in the foreseeable future. Consequently, the increasing prevalence of breast cancer contributes significantly to the demand for breast augmentation procedures and implants.
The market is also witnessing advancements in product offerings aimed at enhancing the visualization experience for patients considering breast reconstruction or augmentation. For instance, J.C Aesthetics launched the Digital Consulting Solution (DCS), providing visualization assistance to patients in Europe and Brazil. Moreover, the development of more durable products is another driving force behind market growth. Notably, POLYTECH Health & Aesthetics initiated a Clinical study on SILK LINE, a silk-coated breast implant, in Europe. The approval and introduction of such innovative products are anticipated to create a more lucrative environment for market expansion.
About VynZ Research:
VynZ Research is a global market research firm offering research, analytics, and consulting services on business strategies. VynZ has a recognized trajectory record and our research database is used by many renowned companies and institutions in the world to strategize and revolutionize business opportunities. The company focuses on providing valuable insights on various technology verticals such as Chemicals, Automotive, Transportation, Energy, Consumer Durables, Healthcare, ICT and other emerging technologies.
Contact Us:
Address: H.O — 9591 Fontainebleau Blvd. 617 Miami Florida 33172 U.S.A
Phone: +91 9960 288 381
Toll Free:1 888 253 3960
Email: marketing@vynzresearch.com
Website: www.vynzresearch.com
Comments
Post a Comment